Instrument Inactif

Cours MAP Pharmaceuticals Inc.

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	26/01/13
MAP Pharmaceuticals Inc. : Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.	24/01/13
MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	24/01/13
MAP Pharmaceuticals Inc. : INVESTOR ALERT: Brannon Law Firm, L.L.C. is Investigating the Proposed Tender Offer/Merger of MAP Pharmaceuticals, Inc. by Allergan, Inc.	23/01/13
MAP Pharmaceuticals Inc. : Law Firm Brower Piven Announces Investigation of MAP Pharmaceuticals, Inc.	23/01/13

Secteur

	Varia. 1 janv.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,51%	103 Md
REGENERON PHARMACEUTICALS, INC.	+1,79%	95,28 Md
ARGENX SE	+1,46%	22,15 Md
BIONTECH SE	-15,54%	21,02 Md
GENMAB A/S	-8,58%	18,15 Md
WUXI APPTEC CO., LTD.	-38,74%	16,73 Md
BEIGENE, LTD.	-12,61%	16,05 Md
NEUROCRINE BIOSCIENCES, INC.	+5,49%	13,68 Md
SAREPTA THERAPEUTICS, INC.	+34,45%	12,17 Md